Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
AZB & Partners has submitted the disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 Financial Results & Limited Review for Dec 31, 2013
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013. Closure for Trading Window
Pfizer Ltd has informed BSE that a Meeting of the Board of Directors of the Company scheduled to be held on January 31, 2014, inter alia, to consider and take on record the Unaudited Financial Results for the third quarter and nine months ended December 31, 2013.Further the Company has informed that, the Trading Window for trading in the Equity shares of the Company is closed from January 22, 2014 to January 31, 2014, both days inclusive. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Pfizer Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Pfizer Ltd and Wyeth Ltd to Merge, Creating a Single Pfizer Brand
Pfizer Ltd has informed BSE regarding a Press Release dated November 23, 2013 titled "Pfizer Ltd and Wyeth Ltd to Merge, Creating a Single Pfizer Brand". Fixes Record Date for Interim Dividend
Pfizer Ltd has informed BSE that the Board of Directors at their meeting held on November 23, 2013 has fixed the record date for payment of interim dividend as December 06, 2013 for the purpose of determining the eligibility of shareholders for payment of interim dividend. Board approve Interim Dividend & Scheme of Amalgamation
Pfizer Ltd has informed BSE that the Board of Directors of the Company (Board) at their meeting held on November 23, 2013 has approved the payment of Interim Dividend of Rs. 360/- per equity share of Rs. 10/- each (3600%) to the shareholders of the Company. The said interim dividend will be paid on December 17, 2013.Further the Company has informed that, the Board also considered and approved the Scheme of Amalgamation of the Wyeth Ltd... Board to consider Interim Dividend
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 23, 2013, inter alia, to transact the following;1. To consider a Scheme of Amalgamation of the Wyeth Limited with the Company.2. To consider declaration of Interim Dividend. Financial Results & Limited Review for Sept 30, 2013
Pfizer Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended Sept 30, 2013. Updates on Outcome of AGM
Pfizer Ltd has submitted to BSE a copy of minutes of the 62nd Annual General Meeting of the Company held on September 06, 2013.